Omega Fund Management, LLC

13F Portfolio Filings

Most recent 13F
Q1 2025
Location
Boston, MA
CIK
0001637359
Alternate names
Omega Fund Management (US) Inc.
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q1 2025 13 169,462 Kestra Med Technologies Ltd., BCAX, Beta Bionics Inc., NUVB 13F-HR 5/15/2025 000095012325005509
Q4 2024 1 33,476 UPB NEW HOLDINGS 5/15/2025 000095012325005507
Q4 2024 11 120,707 BCAX, NUVB, REPL, LXEO 13F-HR 2/14/2025 000095012325002355
Q3 2024 11 160,008 Bicara Therapeutics Inc., NUVB, REPL, LXEO 13F-HR 11/14/2024 000095012324011486
Q2 2024 11 134,971 NUVB, LXEO, REPL, ENGN 13F-HR 8/14/2024 000095012324008730
Q1 2024 11 155,010 NUVB, LXEO, REPL, ENGN 13F-HR 5/14/2024 000095012324005045
Q4 2023 14 123,436 LXEO, REPL, NUVB, enGene Holdings Inc. 13F-HR 2/14/2024 000095012324002504
Q3 2023 12 108,875 REPL, NUVB, IKNA, MORF 13F-HR 11/14/2023 000095012323010476
Q2 2023 12 178,485 REPL, NUVB, ALPN, MORF 13F-HR 8/14/2023 000095012323007696
Q1 2023 14 153,322 REPL, NUVB, MORF, ALPN 13F-HR 5/15/2023 000095012323005263
Q4 2022 16 296,715 Imago Biosciences, REPL, NUVB, MORF 13F-HR 2/13/2023 000095012323002007
Q3 2022 19 273,064 REPL, Imago Biosciences, NUVB, CINC 13F-HR 11/14/2022 000095012322012070
Q2 2022 21 313,294 REPL, NUVB, Imago Biosciences, MORF 13F-HR 8/15/2022 000095012322009090
Q1 2022 22 488,614 NUVB, REPL, Imago Biosciences, MORF 13F-HR 5/13/2022 000095012322005699
Q4 2021 22 707,272 NUVB, REPL, Imago Biosciences, MORF 13F-HR 2/14/2022 000095012322002360
Q3 2021 26 891,379 NUVB, REPL, KRON, MORF 13F-HR 11/15/2021 000095012321015480
Q2 2021 2 279,245 NUVB, SANA NEW HOLDINGS 11/15/2021 000095012321015607
Q2 2021 21 604,351 REPL, MORF, KRON, IKNA 13F-HR 8/16/2021 000095012321011084
Q1 2021 2 323,059 NUVB, SANA NEW HOLDINGS 11/15/2021 000095012321015603
Q1 2021 22 734,164 REPL, MORF, KRON, IKNA 13F-HR 5/17/2021 000095012321006880
Q4 2020 19 666,876 REPL, KRON, MORF, SPRB 13F-HR 2/16/2021 000095012321002713
Q3 2020 16 369,660 REPL, MORF, GOSS, IMUX 13F-HR 11/16/2020 000095012320011928
Q2 2020 15 365,744 REPL, MORF, GOSS, ARQT 13F-HR 8/17/2020 000095012320009147
Q1 2020 16 241,630 REPL, MORF, GOSS, ARQT 13F-HR 5/14/2020 000095012320004802
Q4 2019 14 314,167 GOSS, REPL, MORF, TBIO 13F-HR 2/13/2020 000095012320001796
Q3 2019 14 324,015 GOSS, REPL, MORF, TBIO 13F-HR 11/13/2019 000095012319010754
Q2 2019 15 392,079 GOSS, REPL, MORF, TBIO 13F-HR 8/13/2019 000095012319007724
Q1 2019 13 311,888 GOSS, REPL, TBIO, PRTK NEW HOLDINGS 5/20/2019 000095012319005615
Q1 2019 12 161,207 REPL, TBIO, PRTK, OBSV 13F-HR 5/15/2019 000095012319005079
Q4 2018 14 134,874 REPL, TBIO, KZR, PRTK 13F-HR 2/11/2019 000095012319001091
Q3 2018 14 211,385 REPL, PRTK, TBIO, OBSV 13F-HR 11/7/2018 000095012318010593
Q2 2018 13 135,522 TBIO, PRTK, OBSV, KZR 13F-HR 8/2/2018 000095012318007267
Q1 2018 12 101,754 PRTK, SNNA, OBSV, JNCE 13F-HR 5/4/2018 000095012318004151
Q4 2017 12 138,312 PRTK, JUNO, SNNA, OBSV 13F-HR 2/5/2018 000095012318000798
Q3 2017 11 176,759 PRTK, JUNO, FGEN, SNNA 13F-HR 11/3/2017 000095012317009490
Q2 2017 11 160,239 PRTK, JUNO, FGEN, NBRV 13F-HR 7/26/2017 000095012317006325
Q1 2017 11 153,841 PRTK, JUNO, FGEN, EGLTQ 13F-HR 5/9/2017 000095012317004097
Q4 2016 12 123,236 PRTK, JUNO, EGLTQ, FGEN 13F-HR 2/10/2017 000095012317001390
Q3 2016 11 130,994 JUNO, PRTK, EGLTQ, FGEN 13F-HR 11/2/2016 000095012316021058
Q2 2016 11 134,798 JUNO, PRTK, EGLTQ, FGEN 13F-HR 8/3/2016 000095012316018706
Q1 2016 11 144,173 JUNO, PRTK, EGLTQ, FGEN 13F-HR 5/2/2016 000095012316016121
Q4 2015 10 179,685 JUNO, PRTK, EGLTQ, FGEN 13F-HR 2/10/2016 000095012316013919
Q3 2015 10 177,613 JUNO, PRTK, EGLTQ, FGEN 13F-HR 11/4/2015 000095012315010742
Q2 2015 7 198,055 JUNO, PRTK, EGLTQ, FGEN 13F-HR 8/10/2015 000095012315008290
Q1 2015 7 231,250 JUNO, PRTK, EGLTQ, FGEN 13F-HR 5/11/2015 000095012315005268
Q4 2014 7 217,389 PRTK, JUNO, FGEN, EGLTQ 13F-HR 3/23/2015 000095012315004059